Skip to main content
. 2018 Oct 13;47(Database issue):D590–D595. doi: 10.1093/nar/gky962

Figure 5.

Figure 5.

A comparison of signaling pathways activated by the oncoprotein K1 of KSHV and the oncogene EML4–ALK in non-small cell lung cancer. The pathways are involved in sustaining proliferative signaling and resisting cell death.